FDA Rejects Merck's Combo Cholesterol Drug For Now
Merck & Co. Inc. said Monday that federal regulators have rejected its new cholesterol drug combining the drug giant's own Zetia product with generic Lipitor, telling Merck that they need additional...To view the full article, register now.
Already a subscriber? Click here to view full article